Evidence map›Paper›PMID 35138168›Full record

ArticleMicrobiology spectrum2022

Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.

Tian Deng, Yuqian Jia, Ziwen Tong, Jingru Shi, Zhiqiang Wang, Yuan Liu

Abstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Evolution, Mechanisms, and Therapeutic Implications of Mobile Tetracycline Destructases.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  4. Article
  5. Discovery of HAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Molecular mechanisms of tigecycline-resistance amongFrontiers in cellular and infection microbiology · 2024
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tian DengCollege of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu, China.
Yuqian JiaCollege of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu, China.
Ziwen TongCollege of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu, China.
Jingru ShiCollege of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu, China.
Zhiqiang WangCollege of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu, China.ORCID 0000-0001-6486-9600
Yuan LiuCollege of Veterinary Medicine, Yangzhou Universitygrid.268415.c, Yangzhou, Jiangsu, China.ORCID 0000-0002-9622-6471

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance has caused a serious threat to public health and human safety. Recently, the emergence of novel resistance gene

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsBacterial ProteinsBismuthGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansMicrobial Sensitivity TestsMolecular Docking SimulationTigecyclineAnti-Bacterial AgentsBacterial ProteinsBismuthTigecyclineantibiotic adjuvantbismuth drugsGram-negative bacteriatet(X)

Identifiers

PMID35138168
PMCPMC8826830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.